Indicated as founded in 2016 in one source and 2018 in another, SyntaxBio is described as addressing development of a CRISPR/Cas9-based, genetic programming platform designed to address the convertion of cells into biological computers using DNA-based instructions that read like lines of code. SyntaxBio's platform is designed program cells without the need for consistent external intervention